Titin Isoform Switch
Definition
The titin isoform switch refers to changes in the relative proportion of the two principal cardiac titin isoforms — the short, stiff N2B (3 MDa) and the longer, more compliant N2BA (3.2–3.8 MDa) — within the sarcomere. Because titin is the dominant determinant of cardiomyocyte passive stiffness, shifts in this ratio alter myocardial distensibility, diastolic filling, and the Frank-Starling response. Isoform switching occurs in both development and acquired/inherited heart disease.
Key Concepts
Normal Cardiac Titin Isoforms
- Four principal cardiac isoforms: N2B (dominant adult, stiff), N2BA (more compliant, multiple splice variants), Novex-3 (~650 kDa, structural/regulatory via obscurin interaction), and Cronos (2.3 MDa, internal promoter, predominantly expressed in developing CMs, ~10% of adult titin pool). (sources/TTN-CVResearch-2022, rating: high)
- N2B vs N2BA spring properties: N2B has only 6 PEVK repeats, no middle-Ig domains, no N2A element → short spring, high stiffness. N2BA has longer I-band with more PEVK repeats, middle-Ig domains, and N2A element → longer spring, greater compliance. (sources/TTN-CVResearch-2022, rating: high)
- Healthy adult left ventricle: N2BA:N2B ratio ~30:70 to 40:60. Relatively stable during normal ageing. (sources/TTN-CVResearch-2022, rating: high)
RBM20 — Master Regulator of the Switch
- Splicing factor RBM20 (RNA-binding motif protein 20) suppresses inclusion of I-band TTN exons → promotes shorter, stiffer N2B isoform. (sources/TTN-CVResearch-2022, rating: high)
- Insulin, thyroid hormone (T3), and angiotensin II promote N2B expression via RBM20 pathways — relevant in cardiac development. (sources/TTN-CVResearch-2022, rating: high)
- Foetal hearts express long, compliant N2BA isoforms → very low titin stiffness. Perinatal switch to shorter adult N2BA + N2B → marked stiffness increase. (sources/TTN-CVResearch-2022, rating: high)
- RBM20 feedback loop: Spliced-out regions of TTN form circular RNAs (e.g. cTTN1) that regulate RBM20 and SRSF10 activity — a novel layer of titin autoregulation. (sources/TTN-CVResearch-2022, rating: high)
- RBM20 pathogenic variants (human DCM): Cause oversized N2BA isoforms, greater titin compliance, irregular calcium homeostasis → DCM. Classified as a high-risk genotype with arrhythmogenic potential. (sources/TTN-CVResearch-2022, rating: high); see also entities/DCM.
Isoform Switch in Heart Disease
- In HFrEF (e.g. DCM, ischaemic disease), HFpEF, and aortic stenosis: relative increase in N2BA vs N2B → lower titin-based passive stiffness → increased end-diastolic volume. (sources/TTN-CVResearch-2022, rating: high)
- Conflicting data: Some studies in aortic stenosis and HFpEF report a reduced N2BA:N2B ratio or no change. Discrepancies may reflect: disease stage at sampling, HF subtype, heart chamber, and methodological differences. Whether isoform switch causes or compensates for cardiac stiffness changes in disease is not fully established. (sources/TTN-CVResearch-2022, rating: high)
Mechanical Consequences: Frank-Starling and LDA
- Titin spring stiffness modulates length-dependent activation (LDA) — the immediate increase in myofilament Ca²⁺ sensitivity with cardiomyocyte stretch that underlies the Frank-Starling law. (sources/TTN-CVResearch-2022, rating: high)
- Stiff (N2B-enriched) titin → greater LDA → augmented cardiac output at increased filling.
- Compliant (N2BA-enriched) titin → blunted LDA → reduced Frank-Starling response → impaired cardiac output under increased preload, as seen in HFrEF. (sources/TTN-CVResearch-2022, rating: high)
- RBM20-deficient rats (producing only long N2BA, no N2B) show dilated ventricles and severely blunted LDA. (sources/TTN-CVResearch-2022, rating: high)
Therapeutic Targeting of Isoform Switch
- RBM20 inhibition in animal models increases N2BA:N2B ratio → lower stiffness → improved diastolic function in HFpEF-like models. (sources/TTN-CVResearch-2022, rating: high)
- Limitation: RBM20 regulates many cardiac proteins beyond titin (including Ca²⁺-handling proteins); non-specific RBM20 inhibition risks adverse effects on calcium homeostasis and arrhythmia risk. (sources/TTN-CVResearch-2022, rating: high)
- No approved therapy targeting titin isoform switching exists. Titin-specific splicing modulation (bypassing RBM20 pleiotropy) remains an unmet research goal. (sources/TTN-CVResearch-2022, rating: high)
Contradictions / Open Questions
- Causal vs. compensatory isoform shift in HF: Increased N2BA proportion in failing hearts may lower stiffness as a maladaptive response to chamber dilation, or as an adaptive attempt to reduce filling pressures. The direction of causality has not been definitively established in humans. (sources/TTN-CVResearch-2022, rating: high)
- Conflicting isoform data across HF types: Some HFpEF and aortic stenosis studies report lower (not higher) N2BA:N2B — opposite to the predominant HFrEF finding. Stage, chamber, and method of assessment likely contribute to this heterogeneity, but no consensus framework exists. (sources/TTN-CVResearch-2022, rating: high)
Connections
- Related to entities/TTN
- Related to concepts/Titin-PTMs
- Related to concepts/HFpEF
- Related to entities/Heart-Failure
- Related to entities/DCM